Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Nabi and the NIDA begin toxicity studies of Nabi-NicVAX

March 9, 2000

Nabi-NicVAX attenuates nicotine dependence in rats

March 1, 2000

Study disproves earlier reports of serious treatment-related side effect of deferiprone

Feb. 24, 2000

Elan/Endorex joint venture to develop iron-chelating products with Schein

Feb. 24, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

Ecopipam is able to attenuate the mood-altering and other effects of acute cocaine

Feb. 10, 2000

Antizol granted conditional priority review by Canadian authorities

Feb. 8, 2000

Piperidine, pyrrolidine and pyrroline derivatives selectively affect 5-HT function

Feb. 2, 2000

New series from Lilly affecting serotonergic pathways

Feb. 1, 2000

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Jan. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...